Hantz Financial Services Inc. lessened its holdings in shares of Bruker Corporation (NASDAQ:BRKR – Free Report) by 28.1% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 39,126 shares of the medical research company’s stock after selling 15,317 shares during the period. Hantz Financial Services Inc.’s holdings in Bruker were worth $2,533,000 at the end of the most recent reporting period.
A number of other institutional investors have also modified their holdings of BRKR. Russell Investments Group Ltd. grew its holdings in shares of Bruker by 140.8% during the third quarter. Russell Investments Group Ltd. now owns 29,990 shares of the medical research company’s stock valued at $1,942,000 after purchasing an additional 17,534 shares during the last quarter. Maryland State Retirement & Pension System raised its position in shares of Bruker by 23.2% during the 3rd quarter. Maryland State Retirement & Pension System now owns 6,287 shares of the medical research company’s stock worth $407,000 after purchasing an additional 1,185 shares during the period. AlphaCore Capital LLC bought a new stake in shares of Bruker in the 3rd quarter worth approximately $410,000. Allspring Global Investments Holdings LLC lifted its holdings in shares of Bruker by 5.6% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 169,766 shares of the medical research company’s stock worth $10,515,000 after purchasing an additional 8,938 shares during the last quarter. Finally, Brighton Jones LLC lifted its holdings in shares of Bruker by 11.2% in the 3rd quarter. Brighton Jones LLC now owns 12,436 shares of the medical research company’s stock worth $805,000 after purchasing an additional 1,248 shares during the last quarter. Institutional investors own 79.52% of the company’s stock.
Analysts Set New Price Targets
A number of research firms recently issued reports on BRKR. Guggenheim boosted their price objective on Bruker from $70.00 to $72.00 and gave the company a “buy” rating in a research report on Thursday, October 1st. Barclays increased their target price on Bruker from $58.00 to $70.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 7th. Zacks Research cut Bruker from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, September 2nd. TD Cowen raised their target price on Bruker from $60.00 to $62.00 and gave the company a “hold” rating in a research note on Tuesday, October 13th. Finally, Leerink Partners boosted their price target on shares of Bruker from $80.00 to $85.00 and gave the company an “outperform” rating in a report on Thursday, November 5th. Two research analysts have rated the stock with a Strong Buy rating, five have given a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Bruker has a consensus rating of “Moderate Buy” and an average target price of $60.57.
Bruker Trading Up 1.2%
Shares of Bruker stock opened at $61.36 on Wednesday. The business has a fifty day simple moving average of $59.59 and a 200-day simple moving average of $51.06. Bruker Corporation has a fifty-two week low of $32.37 and a fifty-two week high of $68.98. The firm has a market cap of $9.37 billion, a price-to-earnings ratio of -55.78, a price-to-earnings-growth ratio of 1.76 and a beta of 1.26. The company has a quick ratio of 0.90, a current ratio of 1.84 and a debt-to-equity ratio of 0.74.
Bruker (NASDAQ:BRKR – Get Free Report) last issued its quarterly earnings results on Wednesday, November 4th. The medical research company reported $0.56 EPS for the quarter, topping the consensus estimate of $0.42 by $0.14. Bruker had a negative net margin of 3.82% and a positive return on equity of 13.76%. The firm had revenue of $874.00 million for the quarter, compared to analysts’ expectations of $865.16 million. During the same period in the previous year, the business earned $0.45 earnings per share. Bruker’s revenue for the quarter was up 1.6% compared to the same quarter last year. On average, equities analysts forecast that Bruker Corporation will post 2.13 EPS for the current fiscal year.
Bruker Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 7th. Investors of record on Monday, December 21st will be paid a dividend of $0.05 per share. The ex-dividend date of this dividend is Monday, December 21st. This represents a $0.20 annualized dividend and a yield of 0.3%. Bruker’s dividend payout ratio is currently -18.18%.
Insider Buying and Selling
In related news, VP Mark Munch sold 2,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 15th. The shares were sold at an average price of $52.87, for a total transaction of $105,740.00. Following the completion of the sale, the vice president directly owned 134,806 shares in the company, valued at approximately $7,127,193.22. This trade represents a 1.46% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 27.20% of the stock is currently owned by corporate insiders.
Bruker Company Profile
Bruker develops and manufactures scientific instruments and analytical technologies used to study biological, chemical and physical materials. Its products support research and testing in areas including life sciences, pharmaceuticals, biotechnology, materials science, chemicals and clinical diagnostics. The company’s offerings include nuclear magnetic resonance and electron paramagnetic resonance systems, mass spectrometers, X-ray and microscopy instruments, and infrared and Raman spectroscopy solutions.
See Also
- Five stocks we like better than Bruker
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Want to see what other hedge funds are holding BRKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bruker Corporation (NASDAQ:BRKR – Free Report).
Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.
